The aim of the Centre is to contribute to the improvement of outcomes for eye-care. This will be achieved by expanding the evidence base for clinical interventions, particularly patient-centred outcomes, informing professionals who deliver eye-care of the evidence base and increasing access to care. The Centre will increase the evidence base by expanding the Australian Corneal Graft Registry, establishing other national registries, and by conducting clinical trials. It will increase access to ca ....The aim of the Centre is to contribute to the improvement of outcomes for eye-care. This will be achieved by expanding the evidence base for clinical interventions, particularly patient-centred outcomes, informing professionals who deliver eye-care of the evidence base and increasing access to care. The Centre will increase the evidence base by expanding the Australian Corneal Graft Registry, establishing other national registries, and by conducting clinical trials. It will increase access to care by establishing new models of eye care delivery for common eye problems in urban and remote populations and by developing efficient and cost-effective pathways to care which utilise a wide range of eye-care professionals.Read moreRead less
Methodological Research In Meta-analysis And Evidence Synthesis: An Evidence-based Methods Approach
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Systematic reviews synthesize available research to determine whether policy, health service delivery, public health, and clinical interventions are effective. Statistical methods underpin the validity of the findings in systematic reviews. This research will evaluate and develop statistical methods for systematic reviews with the aim of improving the quality of reviews and ensuring healthcare decisions are based on reliable research syntheses.
Extracellular Acidification And Its Role In Disease
Funder
National Health and Medical Research Council
Funding Amount
$371,529.00
Summary
This proposal focuses on the diseases cystic fibrosis and acute pancreatitis for which there are currently no treatments. In both diseases the affected organs become strongly acidic. Furthermore, these acid changes can be causal in disease progression. However, the source of this acidification is remains unknown. We will identify the routes of acid secretion, the causal role of acidification in disease progression and the effectiveness of treatments aimed at restoring acid-base balance.
Increasing Value, Reducing Waste From Incomplete Or Unusable Reports Of Medical Research
Funder
National Health and Medical Research Council
Funding Amount
$788,486.00
Summary
We estimated that the avoidable waste in research - from design flaws, non-publication, and inadequate reporting - results in over $85 Billion annual loss. I will research innovations to reduce this waste. My focus is particularly on non-drug interventions - exercises, dietary changes, self-monitoring, e-health applications – which are often effective but more difficult to use in clinical practice, and being compiled in my recently founded Handbook of Non-Drug Interventions (see RACGP website).
Testing, Translation And Uptake Of Evidence In General Practice: A Systems Approach To Rapid Translation
Funder
National Health and Medical Research Council
Funding Amount
$2,411,050.00
Summary
Testing, Translation & Uptake of Evidence in General Practice: A systems approach. Though General Practice is the frontline of Australia’s health system, new research findings are often ignored by busy GPs, resulting in suboptimal care. We plan to improve this by: A. A network of influential GPs practices to test new research, B. Practice support units who provide GP and patient summaries of new research, C. Active transfer of successful new practices via social media, guidelines, and courses.
Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network
Funder
National Health and Medical Research Council
Funding Amount
$2,497,654.00
Summary
Arthritis and musculoskeletal conditions place an immense and growing burden on the world’s population. They affect 28% of Australians (>6.1 million people). With the support of CRE funding, the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network will optimise musculoskeletal health through high quality, collaborative clinical research, building research capacity and effective transfer of research outcomes into clinical practice and health policy.